AHF Files Appeal Over Its Claim That Apexus Did Not Obtain Sub-Ceiling Discounts

Judge Percy Anderson
AHF appealed a ruling to dismiss by U.S. District Judge Percy Anderson over AHF's claim that Apexus did not obtain sub-ceiling discounts..
The AIDS Healthcare Foundation (AHF) recently filed an appeal to an April district court dismissal of its case against Apexus, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Center Challenging 340B Patient Definition Responds to HRSA’s and Drug Companies’ Court Arguments

Genesis
Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.
There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk Providing 340B Refunds on Blockbuster Drug Ozempic

Ozempic package
Drugmaker Novo Nordisk is issuing 340B refunds for certain purchases of its blockbuster diabetes medication Ozempic.
Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHIP Objects to Hospital Efforts to Target Medicare Advantage 340B ‘Windfall’

Matthew Eyles
Matthew Eyles, president and CEO of AHIP, objected to hospital-sought rules that target the Medicaid Advantage 340B "windfall."
The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Centers Appeal Loss in California Medicaid Lawsuit

Michelle Baass headshot
Michelle Baass, director of the California Department of Health Care Services, was the defendant in a California Medicaid lawsuit by health centers.
California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Driving Anti-Competitive Health System Tactics, Says Lawsuit

Jefferson Health building
An independent cancer care practice filed a federal lawsuit against Jefferson Health related to the 340B program.
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

HRSA headquarters
The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.
Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Grants 340B Enrollment Flexibility in Georgia Due to Hurricane

Damage from Hurricane Idalia in Georgia
Hurricane Idalia cleanup in Uvalda, Georgia., on Aug. 31.
Eligible covered entities in Georgia may enroll in the 340B program immediately, rather than having to wait for the next [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Jazz Pharmaceuticals Is 25th Drugmaker to Implement Contract Pharmacy Restrictions

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.
Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Withdraws Some Health Centers’ 340B Pricing at Contract Pharmacies

Sanofi headquarters
Sanofi has recently denied some health centers access to 340B pricing at contract pharmacies after saying they did not conform to Sanofi's policy.
Drug manufacturer Sanofi recently started denying access for some health centers to 340B pricing at contract pharmacies after previously saying [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live